Delivery Order SPE2DB22D2206-SPE2DB25FKB12
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a $9,127.32 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 29, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) valued at $3,603.95. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,211.66 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,014.95 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $1,270.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a ceiling value of $1,159.29. This firm fixed-price delivery order, which is set to be completed by August 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involved no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 30, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $10,329.51. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by September 2, 2025. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order valued at $7,914.33 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract. The award, executed on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction and is a major pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB12Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,571.07 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. Kerendia, used primarily in the treatment of chronic kidney disease, exemplifies the specialized pharmaceutical commodities provided through this prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 9/22/25 |